RU-28251
| Clinical data | |
|---|---|
| Other names | RU28251 |
| Drug class | Dopamine receptor agonist; D2-like receptor agonist; Prolactin inhibitor |
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C17H24N2 |
| Molar mass | 256.393 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
RU-28251 is a tricyclic dopamine receptor agonist of the simplified or partial ergoline family. It is a selective D2-like receptor agonist. The drug inhibits prolactin secretion in animals. RU-28251 was first described in the literature by 1978.